{"organizations": [], "uuid": "825e55fc8bcdf269357a808ee9b917aaa49d329d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180403.html", "section_title": "Archive News &amp; Video for Tuesday, 03 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/ip-ferring/ferring-may-proceed-with-case-over-gavis-proposed-generic-prepopik-idUSL2N1RH00J", "country": "US", "domain_rank": 408, "title": "Ferring may proceed with case over Gavis' proposed generic Prepopik", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.746, "site_type": "news", "published": "2018-04-04T08:15:00.000+03:00", "replies_count": 0, "uuid": "825e55fc8bcdf269357a808ee9b917aaa49d329d"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/ip-ferring/ferring-may-proceed-with-case-over-gavis-proposed-generic-prepopik-idUSL2N1RH00J", "ord_in_thread": 0, "title": "Ferring may proceed with case over Gavis' proposed generic Prepopik", "locations": [], "entities": {"persons": [{"name": "ferring", "sentiment": "negative"}, {"name": "gavis", "sentiment": "negative"}, {"name": "mary pat thynge", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "wilmington", "sentiment": "none"}, {"name": "delaware", "sentiment": "none"}, {"name": "prepopik", "sentiment": "none"}], "organizations": [{"name": "prepopik ferring pharmaceuticals", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "gavis pharmaceuticals llc", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Ferring Pharmaceuticals may proceed with a lawsuit seeking a declaration that generic pharmaceutical maker Gavis Pharmaceuticals LLC infringed patents covering pre-colonoscopy drug Prepopik, a federal magistrate judge has ruled.\nU.S. Magistrate Judge Mary Pat Thynge in Wilmington, Delaware, on Monday rejected arguments Ferring’s claims should be tossed since Gavis’ application to produce a generic version of Prepopik has not been approved by the U.S. Food and Drug Administration and no imminent threat of infringement existed.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2q55FIU\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://bit.ly/2q55FIU", "https://instagram.com/reuters/"], "published": "2018-04-04T08:15:00.000+03:00", "crawled": "2018-04-04T12:26:23.009+03:00", "highlightTitle": ""}